This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Qurient Co., Ltd.
Drug Names(s): Q501
Description: Q501 is an orally available 5-lipoxygenase (5-LO) inhibitor.
Additional information available to subscribers only: